A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses

Peptides

Volumn 48, Issue , 2013, Pages 96-105

  Sample, Christopher J ^a   Hudak, Kathryn E ^a   Barefoot, Brice E ^a   Koci, Matthew D ^b   Wanyonyi, Moses S ^a   Abraham, Soman ^a,c   Staats, Herman F ^a   Ramsburg, Elizabeth A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antiviral; Host defense peptide; Mastoparan

Indexed keywords

ANTIVIRUS AGENT; MASTOPARAN 7 NATURAL HOST DEFENSE PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; COWPOX VIRUS; CULTURE MEDIUM; FEMALE; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; INFLUENZA VIRUS A; INOCULATION; LIPID BILAYER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS CORE; VIRUS ENVELOPE; VIRUS INACTIVATION; VIRUS INFECTIVITY; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

INVERTEBRATA; MAMMALIA;

ANTIVIRAL; HOST DEFENSE PEPTIDE; MASTOPARAN;

ANIMALS; ANTIVIRAL AGENTS; HUMANS; INVERTEBRATES; MICE; MICROSCOPY, ELECTRON; PEPTIDES; VIRUSES; WASP VENOMS;

EID: 84886937495     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.07.014     Document Type: Article

References (58)

1. Albiol Matanic VC, Castilla V. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. International Journal of Antimicrobial Agents 2004;23: 382-9. (Pubitemid 38481551)
2. Alekseeva L, Huet D, Femenia F, Mouyna I, Abdelouahab M, Cagna A, et al. Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiology 2009;9:33.
3. Andzhaparidze OG, Bogomolova NN, Boriskin YS, Bektemirova MS, Drynov ID. Comparative study of rabies virus persistence in human and hamster cell lines. Journal of Virology 1981;37: 1-6. (Pubitemid 11174568)
4. Arbuzova A, Schwarz G. Pore kinetics of mastoparan peptides in large unilamellar lipid vesicles. Progress in Colloid and Polymer Science 1996;100: 345-50. (Pubitemid 126463281)
5. Ariki S, Koori K, Osaki T, Motoyama K, Inamori K, Kawabata S. A serine protease zymogen functions as a pattern-recognition receptor for lipopolysaccharides. Proceedings of the National Academy of Sciences of the United States of America 2004;101: 953-8. (Pubitemid 38160565)
6. Bachi T, Howe C. Morphogenesis and ultrastructure of respiratory syncytial virus. Journal of Virology 1973;12: 1173-80.
7. Barefoot B, Thornburg NJ, Barouch DH, Yu JS, Sample C, Johnston RE, et al. Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. Vaccine 2008;26: 6108-18.
8. Barefoot BE, Athearn K, Sample CJ, Ramsburg EA. Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge. Vaccine 2009;28: 79-89.
9. Boman HG, Hultmark D. Cell-free immunity in insects. Annual Review of Microbiology 1987;41: 103-26.
10. Chang TL, Vargas Jr J, DelPortillo A, Klotman ME. Dual role of alphadefensin- 1 in anti-HIV-1 innate immunity. Journal of Clinical Investigation 2005;115: 765-73. (Pubitemid 40322253)
11. Chen HQ, Veluthakal R, Palanivel R, Kowluru A. GTP-binding proteinindependent potentiation by mastoparan of IL-1beta-induced nitric oxide release from insulin-secreting HIT-T15 cells. Apoptosis 2004;9: 145-8. (Pubitemid 38987591)
12. Cho H, Kehrl JH. Regulation of immune function by G protein-coupled receptors, trimeric G proteins, and RGS proteins. Progress in Molecular Biology and Translational Science 2009;86: 249-98.
13. Chowers MY, Lang R, Nassar F, Ben-David D, Giladi M, Rubinshtein E, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infectious Diseases 2001;7: 675-8. (Pubitemid 32845258)
14. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. Journal of Virology 1986;60: 1068-74. (Pubitemid 17179284)
15. Doms RW, Ruusala A, Machamer C, Helenius J, Helenius A, Rose JK. Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. Journal of Cell Biology 1988;107: 89-99.
16. Dos Santos Cabrera MP, Arcisio-Miranda M, Gorjao R, Leite NB, de Souza BM, Curi R, et al. Influence of the bilayer composition on the binding and membrane disrupting effect of Polybia-MP1, an antimicrobial mastoparan peptide with leukemic T-lymphocyte cell selectivity. Biochemistry 2012.
17. Dunn MD, Rossi SL, Carter DM, Vogt MR, Mehlhop E, Diamond MS, et al. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Virology Journal 2010;7: 95.
18. Ellerby HM, Martin SJ, Ellerby LM, Naiem SS, Rabizadeh S, Salvesen GS, et al. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. Journal of Neuroscience 1997;17: 6165-78. (Pubitemid 27329892)
19. Falco A, Mas V, Tafalla C, Perez L, Coll JM, Estepa A. Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): inactivation of virus particles and induction of a type I interferonrelated response. Antiviral Research 2007;76: 111-23. (Pubitemid 47410314)
20. Fang XM, Shu Q, Chen QX, Book M, Sahl HG, Hoeft A, et al. Differential expression of alpha- and beta-defensins in human peripheral blood. European Journal of Clinical Investigation 2003;33: 82-7. (Pubitemid 36051296)
21. Harris A, Cardone G, Winkler DC, Heymann JB, Brecher M, White JM, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proceedings of the National Academy of Sciences of the United States of America 2006;103: 19123-7. (Pubitemid 350002838)
22. Higashijima T, Uzu S, Nakajima T, Ross EM. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). Journal of Biological Chemistry 1988;263: 6491-4.
23. Higashijima T, Wakamatsu K, Takemitsu M, Fujino M, Nakajima T, Miyazawa T. Conformational change of mastoparan from wasp venom on binding with phospholipid membrane. FEBS Letters 1983;152: 227-30. (Pubitemid 13129700)
24. Hollinshead M, Vanderplasschen A, Smith GL, Vaux DJ. Vaccinia virus intracellular mature virions contain only one lipid membrane. Journal of Virology 1999;73: 1503-17. (Pubitemid 29036806)
25. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. Journal of Immunology 2004;172: 1763-7. (Pubitemid 38116824)
26. Jones S, Howl J. Charge delocalisation and the design of novel mastoparan analogues: enhanced cytotoxicity and secretory efficacy of [Lys5, Lys8, Aib10]MP. Regulatory Peptides 2004;121: 121-8. (Pubitemid 38901070)
27. King TP, Jim SY, Wittkowski KM. Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1. International Archives of Allergy and Immunology 2003;131: 25-32. (Pubitemid 36649354)
28. Konrad RJ, Young RA, Record RD, Smith RM, Butkerait P, Manning D, et al. The heterotrimeric G-protein Gi is localized to the insulin secretory granules of beta-cells and is involved in insulin exocytosis. The Journal of Biological Chemistry 1995;270: 12869-76.
29. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infection and Immunity 1998;66: 4222-8. (Pubitemid 28402695)
30. Lee SI, Park KH, Kim SJ, Kang YG, Lee YM, Kim EC. Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clinical and Experimental Immunology 2012;168: 113-24.
31. Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, et al. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Peptides 2011;32: 1518-25.
32. Maisetta G, Di Luca M, Esin S, Florio W, Brancatisano FL, Bottai D, et al. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 2008;29: 1-6. (Pubitemid 350266113)
33. Morimoto M, Mori H, Otake T, Ueba N, Kunita N, Niwa M, et al. Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro. Chemotherapy 1991;37: 206-11.
34. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. Journal of Pharmacology and Experimental Therapeutics 1989;250: 329-35. (Pubitemid 19195009)
35. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nature Reviews Microbiology 2005;3: 13-22. (Pubitemid 40028466)
36. Nagai Y, Ito Y, Hamaguchi M, Yoshida T, Matsumoto T. Relation of interferon production to the limited replication of Newcastle disease virus in L cells. Journal of General Virology 1981;55: 109-16. (Pubitemid 12240516)
37. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. Journal of Immunology 1999;163: 6718-24.
38. Payne LG, Kristenson K. Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. Journal of Virology 1979;32: 614-22. (Pubitemid 10188776)
39. Perron GG, Zasloff M, Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proceedings: Biological Sciences 2006;273: 251-6. (Pubitemid 46768100)
40. Publicover J, Ramsburg E, Robek M, Rose JK. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. Journal of Virology 2006;80: 7028-36. (Pubitemid 44025201)
41. Roberts A, Kretzschmar E, Perkins AS, Forman J, Price R, Buonocore L, et al. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. Journal of Virology 1998;72: 4704-11. (Pubitemid 28215645)
42. Robinson Jr WE, McDougall B, Tran D, Selsted ME. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. Journal of Leukocyte Biology 1998;63: 94-100. (Pubitemid 28070387)
43. Rocha T, de Barros LL, Fontana K, de Souza BM, Palma MS, da Cruz-Hofling MA. Inflammation and apoptosis induced by mastoparan Polybia-MPII on skeletal muscle. Toxicon 2010;55: 1213-21.
44. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME. Alphadefensin inhibits influenza virus replication by cell-mediated mechanism(s). The Journal of Infectious Diseases 2007;196: 835-43. (Pubitemid 47378932)
45. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Critical Reviews in Immunology 2000;20: 407-31. (Pubitemid 32106684)
46. Sieczkarski SB, Brown HA, Whittaker GR. Role of protein kinase C betaII in influenza virus entry via late endosomes. Journal of Virology 2003;77: 460-9. (Pubitemid 36004986)
47. Snoeck E, Wade JR, Duff F, Lamb M, Jorga K. Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin. British Journal of Clinical Pharmacology 2006;62: 699-709. (Pubitemid 44749547)
48. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. European Journal of Cell Biology 1993;60: 163-78. (Pubitemid 23092674)
49. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. New England Journal of Medicine 2004;350: 1179-88.
50. Tzeng YL, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM, et al. Cationic antimicrobial peptide resistance in Neisseria meningitidis. Journal of Bacteriology 2005;187: 5387-96. (Pubitemid 41022958)
51. Vigant F, Lee B. Hendra and nipah infection: pathology, models and potential therapies. Infectious Disorders - Drug Targets 2011;11: 315-36.
52. Wachinger M, Kleinschmidt A, Winder D, von Pechmann N, Ludvigsen A, Neumann M, et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. Journal of General Virology 1998;79(Pt 4): 731-40. (Pubitemid 28161947)
53. Whiles JA, Brasseur R, Glover KJ, Melacini G, Komives EA, Vold RR. Orientation and effects of mastoparan X on phospholipid bicelles. Biophysical Journal 2001;80: 280-93.
54. Yan GM, Lin SZ, Irwin RP, Paul SM. Activation of G proteins bidirectionally affects apoptosis of cultured cerebellar granule neurons. Journal of Neurochemistry 1995;65: 2425-31.
55. Yandek LE, Pokorny A, Almeida PF. Wasp mastoparans follow the same mechanism as the cell-penetrating peptide transportan 10. Biochemistry 2009;48: 7342-51.
56. Yount NY, Yeaman MR. Emerging themes and therapeutic prospects for anti-infective peptides. Annual Review of Pharmacology and Toxicology 2012;52: 337-60.
57. Yu K, Kang S, Park N, Shin J, Kim Y. Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy. Journal of Peptide Research 2000;55: 51-62. (Pubitemid 30038573)
58. Zasloff M. Antimicrobial peptides in health and disease. The New England Journal of Medicine 2002;347: 1199-200.